Open access · US-GOV
via ClinicalTrials.gov Clinical trial
COcoa Supplement and Multivitamin Outcomes Study-Mind
Authors not listed
Wake Forest University Health Sciences · 2016
Abstract
The parent trial (COcoa Supplement and Multivitamin Outcomes Study, COSMOS; NCT02422745) is a randomized clinical trial of cocoa extract supplement (containing a total of 500 mg/d flavanols, including 80 mg. (-)-epicatechins), and a standard multivitamin supplement to reduce the risk of cardiovascular disease and cancer among men aged 60 years and older and women aged 65 years and older. A cognitive ancillary study (COSMOS-Mind) is being conducted among men and women, 65 years and older, who are enrolled in COSMOS and will examine whether the cocoa extract supplement or the multivitamin supplement improves cognitive function and reduces risk of cognitive impairment, including Alzheimer's disease (AD) and other related types of dementia. Participants at the Wake Forest site will only be getting a phone call.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2016). COcoa Supplement and Multivitamin Outcomes Study-Mind. <em>Wake Forest University Health Sciences</em>. https://clinicaltrials.gov/study/NCT03035201
Vancouver
Anonymous. COcoa Supplement and Multivitamin Outcomes Study-Mind. Wake Forest University Health Sciences. 2016.
BibTeX
@misc{anon2016COcoaS,
title = {COcoa Supplement and Multivitamin Outcomes Study-Mind},
author = {Anonymous},
journal = {Wake Forest University Health Sciences},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Augusta University 2015
Open access · US-GOV
Effect of Randomized Cocoa Supplementation on Inflammaging and Epigenetic Aging
Journal of Alzheimer s Disease 2023
Open access · CC-BY
Incidence of Alzheimer’s Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype
Neural Regeneration Research 2021
Open access · CC-BY
Oral frailty and neurodegeneration in Alzheimer’s disease
Medical University of Vienna 2026
Open access · US-GOV
Digitally Supported Lifestyle Programme to Promote Brain Health Among Older Adults - the LETHE-AT Randomised-controlled, Multicentre Pilot Trial
Steven E Arnold, MD 2020
Open access · US-GOV
A Crossover, Randomized Block Sequence, Double-Blind, Placebo-Controlled Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment in Aging
Scale Media Inc 2024
Open access · US-GOV